Davita (DVA) Upgraded at TheStreet

TheStreet upgraded shares of Davita (NYSE:DVA) from a c rating to a b- rating in a research report sent to investors on Thursday morning.

A number of other brokerages also recently commented on DVA. JPMorgan Chase & Co. boosted their target price on Davita from $4.90 to $84.00 and gave the company a strong-buy rating in a research note on Thursday, December 7th. Robert W. Baird restated a hold rating and issued a $63.00 target price on shares of Davita in a research note on Friday, November 10th. Citigroup upgraded Davita from a neutral rating to a buy rating and boosted their target price for the company from $67.71 to $82.00 in a research note on Monday, December 11th. SunTrust Banks set a $70.00 target price on Davita and gave the company a hold rating in a research note on Thursday, December 7th. Finally, Zacks Investment Research downgraded Davita from a hold rating to a sell rating in a research note on Wednesday, October 11th. Two analysts have rated the stock with a sell rating, five have assigned a hold rating, four have issued a buy rating and two have given a strong buy rating to the company’s stock. The company currently has an average rating of Hold and a consensus price target of $76.00.

Davita (DVA) opened at $75.53 on Thursday. The company has a debt-to-equity ratio of 1.79, a current ratio of 1.40 and a quick ratio of 1.35. Davita has a 52 week low of $52.51 and a 52 week high of $75.60. The company has a market capitalization of $13,840.00, a PE ratio of 28.94, a price-to-earnings-growth ratio of 15.06 and a beta of 0.96.

Davita (NYSE:DVA) last issued its earnings results on Tuesday, November 7th. The company reported $0.81 EPS for the quarter, missing analysts’ consensus estimates of $0.94 by ($0.13). Davita had a net margin of 3.40% and a return on equity of 13.31%. The firm had revenue of $3.92 billion during the quarter, compared to analysts’ expectations of $3.91 billion. During the same quarter last year, the firm earned $0.95 EPS. The business’s revenue for the quarter was up 5.2% compared to the same quarter last year. equities research analysts forecast that Davita will post 3.42 EPS for the current fiscal year.

Davita announced that its board has initiated a stock repurchase program on Tuesday, October 10th that authorizes the company to buyback $1.50 billion in shares. This buyback authorization authorizes the company to buy shares of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s board believes its stock is undervalued.

In other news, VP Leanne M. Zumwalt sold 949 shares of the company’s stock in a transaction dated Friday, December 8th. The stock was sold at an average price of $68.19, for a total transaction of $64,712.31. Following the completion of the sale, the vice president now owns 12,423 shares in the company, valued at approximately $847,124.37. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Charles Berg sold 7,048 shares of the company’s stock in a transaction dated Monday, December 11th. The stock was sold at an average price of $69.24, for a total value of $488,003.52. Following the sale, the insider now owns 5,359 shares of the company’s stock, valued at approximately $371,057.16. The disclosure for this sale can be found here. In the last quarter, insiders have sold 117,937 shares of company stock valued at $8,028,379. 2.10% of the stock is currently owned by corporate insiders.

Several institutional investors and hedge funds have recently added to or reduced their stakes in DVA. Schroder Investment Management Group boosted its stake in shares of Davita by 53.9% during the 2nd quarter. Schroder Investment Management Group now owns 49,967 shares of the company’s stock worth $3,201,000 after acquiring an additional 17,497 shares in the last quarter. Riverhead Capital Management LLC boosted its stake in shares of Davita by 10.6% during the 2nd quarter. Riverhead Capital Management LLC now owns 112,506 shares of the company’s stock worth $7,286,000 after acquiring an additional 10,775 shares in the last quarter. Accident Compensation Corp boosted its stake in shares of Davita by 147.5% during the 2nd quarter. Accident Compensation Corp now owns 15,100 shares of the company’s stock worth $978,000 after acquiring an additional 9,000 shares in the last quarter. Cibc World Markets Corp boosted its stake in shares of Davita by 35.3% during the 2nd quarter. Cibc World Markets Corp now owns 22,006 shares of the company’s stock worth $1,425,000 after acquiring an additional 5,746 shares in the last quarter. Finally, Flinton Capital Management LLC boosted its stake in shares of Davita by 10.7% during the 2nd quarter. Flinton Capital Management LLC now owns 152,830 shares of the company’s stock worth $9,898,000 after acquiring an additional 14,756 shares in the last quarter. Institutional investors own 87.94% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Davita (DVA) Upgraded at TheStreet” was first reported by Equities Focus and is owned by of Equities Focus. If you are accessing this report on another publication, it was copied illegally and reposted in violation of United States & international copyright law. The legal version of this report can be viewed at https://www.equitiesfocus.com/2018/01/08/davita-dva-upgraded-at-thestreet.html.

About Davita

DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.

Analyst Recommendations for Davita (NYSE:DVA)

Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply